Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SLP
SLP logo

SLP News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SLP News

Rosen Law Firm Investigates Simulations Plus for Misleading Information

Feb 10 2026Globenewswire

Simulations Plus Extends Collaborations with FDA and NIEHS

Feb 10 2026Businesswire

Simulations Plus Extends Collaborations with FDA and NIEHS

Feb 10 2026Newsfilter

Rosen Law Firm Investigates Simulations Plus Securities Claims

Feb 08 2026PRnewswire

Rosen Law Firm Investigates Securities Claims for Simulations Plus Shareholders

Feb 06 2026Globenewswire

Rosen Law Firm Investigates Simulations Plus Securities Claims

Feb 03 2026PRnewswire

Rosen Law Firm Investigates Securities Claims for Simulations Plus Shareholders

Feb 03 2026Globenewswire

Rosen Law Firm Investigates Securities Claims for Simulations Plus Shareholders

Jan 30 2026Globenewswire

SLP Events

02/09 18:50
Simulations Plus Extends Research Collaborations with FDA and NIEHS
Simulations Plus announced the extension of two separate research collaborations with the U.S. FDA and the National Institute of Environmental Health Sciences, or NIEHS. The extended projects support ongoing federal research efforts focused on the development of new approach methodologies and advancing computational approaches for food and chemical safety assessments. The extended collaborations align with federal initiatives by supporting research into the application, evaluation, and refinement of computational toxicity models. The extended agreement with the FDA's Human Foods Program allows scientists to continue research involving computational models to support chemical safety assessments for food-related substances. New federal funding dedicated to food and chemical safety modernization will provide this collaboration with expanded access to curated toxicological datasets for further training, validation, and benchmarking of Simulations Plus' AI/ML models. The extended collaboration with NIEHS focuses on computational approaches relevant to environmental and exposure-related chemical safety research. NIEHS' collaboration with Simulations Plus is part of a national effort to modernize chemical safety assessment through AI-powered new approach methodologies and will continue the application of the company's software engines to help with the design, validation, and benchmarking of new experimental systems under evaluation.
01/08 16:10
Company Confirms FY26 Revenue Outlook of $79M-$82M
Backs FY26 revenue view $79M-$82M, consensus $80.35M.
01/08 16:10
Simulations Plus Reports Q1 Revenue of $18.4M
Reports Q1 revenue $18.4M, consensus $18.06M. "We met our first quarter revenue guidance and delivered strong performance in our services segment, driven primarily by significant growth in commercialization offerings and modest gains in development projects," said Shawn O'Connor, CEO of Simulations Plus. "In software, the expected decrease in clinical operations and development revenue was only partially offset by an increase in discovery solutions."

SLP Monitor News

No data

No data

SLP Earnings Analysis

No Data

No Data

People Also Watch